P 粒子的形成提高了诺如病毒 P 蛋白的免疫原性。
The formation of P particle increased immunogenicity of norovirus P protein.
机构信息
Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
出版信息
Immunology. 2012 May;136(1):28-9. doi: 10.1111/j.1365-2567.2012.03555.x.
Abstract
As a commentary on a recently published paper in Immunology, this article summaries the principle of norovirus P particle as a promising vaccine against noroviruses. It emphasizes the importance of P particle formation in the immune enhancement of the vaccine and methods for production/verification of high quality P particles which may be easily neglected by researchers.
摘要
作为对最近发表在《免疫学》杂志上的一篇论文的评论，本文总结了诺如病毒 P 粒子作为一种有前途的诺如病毒疫苗的原理。它强调了 P 粒子形成在疫苗免疫增强中的重要性，以及生产/验证高质量 P 粒子的方法，这些方法很容易被研究人员忽视。
相似文献
1
The formation of P particle increased immunogenicity of norovirus P protein.P 粒子的形成提高了诺如病毒 P 蛋白的免疫原性。
Immunology. 2012 May;136(1):28-9. doi: 10.1111/j.1365-2567.2012.03555.x.
2
A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles.诺如病毒 GII-4 病毒样颗粒与 P 颗粒免疫原性比较。
Immunology. 2012 Jan;135(1):89-99. doi: 10.1111/j.1365-2567.2011.03516.x.
3
Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes.仅单独或与不同基因型共同施用 GII.4 病毒样颗粒诱导的诺如病毒特异性抗体和 T 细胞的功能和亲和性。
Vaccine. 2018 Jan 25;36(4):484-490. doi: 10.1016/j.vaccine.2017.12.009. Epub 2017 Dec 13.
4
A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies.双价人诺如病毒疫苗诱导同型和异型中和抗体。
J Infect Dis. 2024 May 15;229(5):1402-1407. doi: 10.1093/infdis/jiad401.
5
Immunogenicity and protective potency of Norovirus GII.17 virus-like particle-based vaccine.基于诺如病毒 GII.17 病毒样颗粒的疫苗的免疫原性和保护效力。
Biotechnol Lett. 2020 Jul;42(7):1211-1218. doi: 10.1007/s10529-020-02837-w. Epub 2020 Feb 22.
6
Pre-existing immunity to norovirus GII-4 virus-like particles does not impair de novo immune responses to norovirus GII-12 genotype.先前对诺如病毒 GII-4 病毒样颗粒的免疫并不影响对诺如病毒 GII-12 基因型的新免疫反应。
Viral Immunol. 2013 Apr;26(2):167-70. doi: 10.1089/vim.2012.0082. Epub 2013 Feb 25.
7
Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus.诺如病毒 P 粒子：一种亚病毒纳米颗粒，可用于开发针对诺如病毒、轮状病毒和流感病毒的疫苗。
Nanomedicine (Lond). 2012 Jun;7(6):889-97. doi: 10.2217/nnm.12.62.
8
Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus.三种病毒衍生纳米颗粒联合作为针对肠道病原体（肠病毒、诺如病毒和轮状病毒）的疫苗。
Vaccine. 2019 Dec 3;37(51):7509-7518. doi: 10.1016/j.vaccine.2019.09.072. Epub 2019 Oct 1.
9
Production, characterization and immunogenicity of P particles derived from norovirus GII.4 genotype 2004 variant.源自诺如病毒GII.4基因型2004变异株的P颗粒的制备、特性鉴定及免疫原性研究
Acta Virol. 2015 Mar;59(1):33-9. doi: 10.4149/av_2015_01_33.
10
Serological Correlates of Protection against a GII.4 Norovirus.针对GII.4型诺如病毒的保护性血清学关联因素
Clin Vaccine Immunol. 2015 Aug;22(8):923-9. doi: 10.1128/CVI.00196-15. Epub 2015 Jun 3.
引用本文的文献
1
Norovirus Binding to Ligands Beyond Histo-Blood Group Antigens.诺如病毒与组织血型抗原以外的配体结合。
Front Microbiol. 2017 Dec 21;8:2549. doi: 10.3389/fmicb.2017.02549. eCollection 2017.
2
Recent advancements in combination subunit vaccine development.联合亚单位疫苗研发的最新进展。
Hum Vaccin Immunother. 2017 Jan 2;13(1):180-185. doi: 10.1080/21645515.2016.1229719.
3
Norovirus vaccines and potential antinorovirus drugs: recent advances and future perspectives.诺如病毒疫苗和潜在的抗诺如病毒药物：最新进展与未来展望。
Future Virol. 2015;10(7):899-913. doi: 10.2217/fvl.15.57.
4
Norovirus.诺如病毒
Clin Microbiol Rev. 2015 Jan;28(1):134-64. doi: 10.1128/CMR.00075-14.
5
Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs.鼻内接种P颗粒疫苗为无菌猪提供了针对人GII.4诺如病毒腹泻的部分交叉变异保护。
J Virol. 2014 Sep 1;88(17):9728-43. doi: 10.1128/JVI.01249-14. Epub 2014 Jun 11.
6
Norovirus P particle efficiently elicits innate, humoral and cellular immunity.诺如病毒 P 粒子能有效地诱导先天、体液和细胞免疫。
PLoS One. 2013 Apr 29;8(4):e63269. doi: 10.1371/journal.pone.0063269. Print 2013.
7
Polyvalent complexes for vaccine development.多价复合物在疫苗开发中的应用。
Biomaterials. 2013 Jun;34(18):4480-92. doi: 10.1016/j.biomaterials.2013.02.041. Epub 2013 Mar 15.
8
Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus.诺如病毒 P 粒子：一种亚病毒纳米颗粒，可用于开发针对诺如病毒、轮状病毒和流感病毒的疫苗。
Nanomedicine (Lond). 2012 Jun;7(6):889-97. doi: 10.2217/nnm.12.62.
本文引用的文献
1
A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles.诺如病毒 GII-4 病毒样颗粒与 P 颗粒免疫原性比较。
Immunology. 2012 Jan;135(1):89-99. doi: 10.1111/j.1365-2567.2011.03516.x.
2
A candidate dual vaccine against influenza and noroviruses.一种候选的流感和诺如病毒联合疫苗。
Vaccine. 2011 Oct 13;29(44):7670-7. doi: 10.1016/j.vaccine.2011.07.139. Epub 2011 Aug 11.
3
Crystallography of a Lewis-binding norovirus, elucidation of strain-specificity to the polymorphic human histo-blood group antigens.路易斯结合诺如病毒的晶体学研究，阐明对多态性人组织血型抗原的特异性。
PLoS Pathog. 2011 Jul;7(7):e1002152. doi: 10.1371/journal.ppat.1002152. Epub 2011 Jul 21.
4
Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution.诺如病毒 GII.4 流行变异株中血凝素-血红细胞抗原结合特异性的结构分析：对新纪元进化的启示。
J Virol. 2011 Sep;85(17):8635-45. doi: 10.1128/JVI.00848-11. Epub 2011 Jun 29.
5
Production and characterization of virus-like particles and the P domain protein of GII.4 norovirus.病毒样颗粒和 GII.4 诺如病毒 P 结构域蛋白的制备和特性。
J Virol Methods. 2012 Jan;179(1):1-7. doi: 10.1016/j.jviromet.2011.05.009. Epub 2011 May 12.
6
Crystal structures of GII.10 and GII.12 norovirus protruding domains in complex with histo-blood group antigens reveal details for a potential site of vulnerability.GII.10 和 GII.12 诺如病毒突起结构域与血型抗原复合物的晶体结构揭示了潜在弱点的详细信息。
J Virol. 2011 Jul;85(13):6687-701. doi: 10.1128/JVI.00246-11. Epub 2011 Apr 27.
7
Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles.诺如病毒 P 结构域的末端修饰导致了一种新型的亚病毒颗粒，即小 P 颗粒。
Virology. 2011 Feb 20;410(2):345-52. doi: 10.1016/j.virol.2010.11.017. Epub 2010 Dec 23.
8
Norovirus P particle, a novel platform for vaccine development and antibody production.诺如病毒 P 粒子：疫苗开发和抗体生产的新型平台。
J Virol. 2011 Jan;85(2):753-64. doi: 10.1128/JVI.01835-10. Epub 2010 Nov 10.
9
Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution.碳水化合物结合界面的保守性：诺如病毒进化过程中人类血型抗原选择的证据
PLoS One. 2009;4(4):e5058. doi: 10.1371/journal.pone.0005058. Epub 2009 Apr 1.
10
Noroviral P particle: structure, function and applications in virus-host interaction.诺如病毒P颗粒：结构、功能及其在病毒-宿主相互作用中的应用
Virology. 2008 Dec 5;382(1):115-23. doi: 10.1016/j.virol.2008.08.047. Epub 2008 Oct 16.
Zotero 插件